<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04904484</url>
  </required_header>
  <id_info>
    <org_study_id>292573</org_study_id>
    <nct_id>NCT04904484</nct_id>
  </id_info>
  <brief_title>A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients</brief_title>
  <acronym>iZephyr</acronym>
  <official_title>A Safety Assessment of the iZephyr Hood for Non Invasive Ventilation in COVID-19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mercedes AMG PETRONAS Formula One Team</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College Healthcare NHS Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a safety assessment of the iZephyr hood a novel aerosol removal device in&#xD;
      patients receiving non invasive ventilation for COVID-19.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Demonstrate that safety and suitability of the iZephyr Hood in patients receiving&#xD;
      non-invasive ventilation (NIV) or high flow oxygen therapy (HFOT).&#xD;
&#xD;
      Determine the user acceptability of the iZephyr Hood in patients receiving NIV and HFOT.&#xD;
&#xD;
      Determine the reduction in aerosol spread of COVID-19 viral particles when using the Zephyr&#xD;
      hood in patients using non-invasive ventilation or high flow oxygen.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Environmental contamination of SARS Co-V2 (air and surface) will be tested around COVID patients receiving Non-invasive ventilation or high flow oxygen therapy before using the iZephyr hood and then with the iZephyr hood in place, to determine if the hood changes the amount of environmental contamination</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the background concentration of SARS-Co-V2 around COVID patients receiving NIV</measure>
    <time_frame>3 month</time_frame>
    <description>Air and surface sampling for SARS Co-V2 around COVID patients receiving non invasive ventilation or high flow oxygen therapy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine the background concentration of SARS-Co-V2 when the iZephyr hood is in use</measure>
    <time_frame>12 months</time_frame>
    <description>Air and surface sampling for SARS Co-V2 around COVID patients receiving non invasive ventilation or high flow oxygen therapy inside an iZephyr hood.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of iZephyr hood on environmental SARS Co-V2 contamination</measure>
    <time_frame>12 months</time_frame>
    <description>Determine if there is a change in the concentration of SARS-Co-V2 virus on the surfaces and in the air samples surrounding a COVID-19 positive patient whilst using the iZephyr compared to when not using the iZephyr.</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Aerosol Disease</condition>
  <condition>Covid19</condition>
  <condition>Noninvasive Ventilation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iZephyr hood</intervention_name>
    <description>Assessment of an aerosol containment device</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Adult COVID-19 negative patients who are requiring non-invasive ventilation (phase II)&#xD;
&#xD;
        Adult COVID-19 positive patients who are requiring non-invasive ventilation (Phase III)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients under the age of 18 years or those lacking capacity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Priscilla Humado</last_name>
    <phone>02033137306</phone>
    <email>priscilla.humado1@nhs.net</email>
  </overall_contact>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 15, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2021</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

